Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Bo Li

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
BMC Medicine|March 5, 2024
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroQing-Qing Duan, Han Wang, Wei-Ming Su, et al.
Chemical Biology & Drug Design|July 31, 2017
Structure-based discovery of new selective small-molecule sirtuin 5 inhibitorsSha Liu, Sen Ji, Zhu-Jun Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2025
Co-delivery of SN38 and SR717 activates cGAS-STING for near-infrared II image-guided chemoimmunotherapyXiaowen Hou, Chunlin Ren, Xiaodong Zeng, et al.
European Journal of Medicinal Chemistry|May 20, 2023
Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitorsYu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, et al.
Bioorganic Chemistry|March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studiesJi Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
Chemical Communications (Cambridge, England)|July 14, 2021
Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistanceYou-Cai Xiao, Xiao-Pan Chen, Ji Deng, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Structural Optimization of Benzyl-5-methyl‑1<i>H</i>‑Imidazole Derivatives as Human Glutaminyl Cyclase InhibitorsYu-Ting Chen, Fan-Bo Meng, Yu-Qing Zhuang, et al.
Journal of Medicinal Chemistry|February 1, 2013
Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivoLing-Ling Yang, Guo-Bo Li, Shuang Ma, et al.
Journal of Chemical Information and Modeling|May 14, 2025
Deciphering Glutaminyl Cyclase Catalytic Pathways Enables Recognition of Anchor Pharmacophores for Inhibitor DiscoveryJing-Wei Wu, Xiang-Li Ning, Biao-Dan Tang, et al.
Journal of Medicinal Chemistry|May 17, 2026
X-ray Crystallography-Guided Discovery of a Potent Dual-Pocket Competitive SIRT5 Inhibitor against Sepsis-Associated AKIYingying Jiang, Lina Yang, Rui Xiong, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
BMC Medicine|March 5, 2024
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroQing-Qing Duan, Han Wang, Wei-Ming Su, et al.
Chemical Biology & Drug Design|July 31, 2017
Structure-based discovery of new selective small-molecule sirtuin 5 inhibitorsSha Liu, Sen Ji, Zhu-Jun Yu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2025
Co-delivery of SN38 and SR717 activates cGAS-STING for near-infrared II image-guided chemoimmunotherapyXiaowen Hou, Chunlin Ren, Xiaodong Zeng, et al.
European Journal of Medicinal Chemistry|May 20, 2023
Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-β-lactamase inhibitorsYu-Hang Yan, Hao-Sheng Ding, Kai-Rong Zhu, et al.
Bioorganic Chemistry|March 30, 2023
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studiesJi Deng, Ze-Min Liu, Kai-Rong Zhu, et al.
Chemical Communications (Cambridge, England)|July 14, 2021
Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistanceYou-Cai Xiao, Xiao-Pan Chen, Ji Deng, et al.
ACS Medicinal Chemistry Letters|March 18, 2026
Structural Optimization of Benzyl-5-methyl‑1<i>H</i>‑Imidazole Derivatives as Human Glutaminyl Cyclase InhibitorsYu-Ting Chen, Fan-Bo Meng, Yu-Qing Zhuang, et al.
Journal of Medicinal Chemistry|February 1, 2013
Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivoLing-Ling Yang, Guo-Bo Li, Shuang Ma, et al.
Journal of Chemical Information and Modeling|May 14, 2025
Deciphering Glutaminyl Cyclase Catalytic Pathways Enables Recognition of Anchor Pharmacophores for Inhibitor DiscoveryJing-Wei Wu, Xiang-Li Ning, Biao-Dan Tang, et al.
Journal of Medicinal Chemistry|May 17, 2026
X-ray Crystallography-Guided Discovery of a Potent Dual-Pocket Competitive SIRT5 Inhibitor against Sepsis-Associated AKIYingying Jiang, Lina Yang, Rui Xiong, et al.
Pageof 8